Megan Honeywell

6PUBLICATIONS
16CO-AUTHORS
Molecular targetsEnvironmental epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 14, 2024
Functional genomic screens with death rate analyses reveal mechanisms of drug action.

Megan E Honeywell, Marie S Isidor, Nicholas W Harper

|Oct 24, 2023
Functional genomics reveals an off-target dependency of drug synergy in gastric cancer therapy.

Ozen Leylek, Megan E Honeywell, Michael J Lee

|Sep 23, 2022
Bacterial diet modulates tamoxifen-induced death via host fatty acid metabolism.

Cédric Diot, Aurian P García-González, Andre F Vieira

|Nov 18, 2020
ELP-dependent expression of MCL1 promotes resistance to EGFR inhibition in triple-negative breast cancer cells.

Peter Cruz-Gordillo, Megan E Honeywell, Nicholas W Harper

|Apr 07, 2020
Drug antagonism and single-agent dominance result from differences in death kinetics.

Ryan Richards, Hannah R Schwartz, Megan E Honeywell

|Aug 08, 2018
Tumor-stroma interactions differentially alter drug sensitivity based on the origin of stromal cells.

Benjamin D Landry, Thomas Leete, Ryan Richards

Pageof 1